SIGRID THERAPEUTICS Trademark

Trademark Overview


On Wednesday, April 15, 2020, a trademark application was filed for SIGRID THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the SIGRID THERAPEUTICS trademark a serial number of 88873084. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 20, 2023. This trademark is owned by Sigrid Therapeutics AB. The SIGRID THERAPEUTICS trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Dietetic preparations adapted for medical use; dietetic substances in the nature of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions adapted for medical use; pharmaceuticals and natural remedies for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; preparations for use in naturopathy for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; nutritional supplements; chemical preparations for medical purposes for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; pharmaceutical preparations and chemico- pharmaceutical preparations for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the impro...

Surgical and medical devices for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; capsulated medical devices for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; medical devices for the treatment and prevention of obesity and being overweight, and for use in weight control; medical devices for the treatment and prevention of prediabetes, diabetes and glycemic control, and for the improvement of overall metabolic health; medical devices for use in the prevention and treatment of prediabetes and diabetes; orally administered medical devices for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; surgical and medical devices, capsulated devices and orally administered medical devices all ...
sigrid therapeutics

General Information


Serial Number88873084
Word MarkSIGRID THERAPEUTICS
Filing DateWednesday, April 15, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 20, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 25, 2020

Trademark Statements


Goods and ServicesDietetic preparations adapted for medical use; dietetic substances in the nature of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions adapted for medical use; pharmaceuticals and natural remedies for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; preparations for use in naturopathy for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; nutritional supplements; chemical preparations for medical purposes for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; pharmaceutical preparations and chemico- pharmaceutical preparations for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; dietary and nutritional supplements; health food supplements for persons with special dietary requirements; chemical preparations for pharmaceutical purposes for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; pharmaceutical preparations and substances for glycemic control; pharmaceutical preparations and substances for the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; dietetic preparations and substances for glycemic control; dietetic preparations and substances for the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; dietary and nutritional supplements for glycemic control; dietary and nutritional supplements for the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; pharmaceutical preparations in the form of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions for use in glycemic control; pharmaceutical preparations in the form of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions for use in the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; pharmaceutical preparations and substances, dietary and nutritional substances in the form of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions, all for use in the treatment and regulation of obesity, body weight, body fat, body composition, body weight circumference, cholesterol and LDL cholesterol levels, liver disease, steatohepatitis, infantile colic, gut microbiota, insulin levels and resistance, blood lipids, diarrhea, constipation, colitis; pharmaceutical preparations and substances, dietary and nutritional substances in the form of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions, all for use in the treatment and regulation of intestinal injury or inflammation, Crohn's disease, cardiovascular risk factors, post bariatric surgery patients, and not including products primarily for use in the treatment of angina pectoris and high blood pressure
Goods and ServicesSurgical and medical devices for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; capsulated medical devices for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; medical devices for the treatment and prevention of obesity and being overweight, and for use in weight control; medical devices for the treatment and prevention of prediabetes, diabetes and glycemic control, and for the improvement of overall metabolic health; medical devices for use in the prevention and treatment of prediabetes and diabetes; orally administered medical devices for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; surgical and medical devices, capsulated devices and orally administered medical devices all for use in the treatment and regulation of obesity, body weight, body fat, body composition, body weight circumference, cholesterol and LDL cholesterol levels, liver disease, steatohepatitis, infantile colic, gut microbiota, insulin levels and resistance, blood lipids, diarrhea, constipation, intestinal injury or inflammation, colitis, Crohn's disease, cardiovascular risk factors, post bariatric surgery patients
Disclaimer with Predetermined Text"THERAPEUTICS"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 24, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, April 24, 2020
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSigrid Therapeutics AB
Party Type20 - Owner at Publication
Legal Entity Type64 - NOT AVAILABLE
AddressSolna SE-17165
SE

Party NameSigrid Therapeutics AB
Party Type10 - Original Applicant
Legal Entity Type64 - NOT AVAILABLE
AddressSolna SE-17165
SE

Trademark Events


Event DateEvent Description
Monday, November 20, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 20, 2023ABANDONMENT - NO USE STATEMENT FILED
Wednesday, March 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 14, 2023SOU EXTENSION 5 GRANTED
Thursday, March 2, 2023SOU EXTENSION 5 FILED
Tuesday, March 14, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, March 2, 2023SOU TEAS EXTENSION RECEIVED
Saturday, September 10, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 8, 2022SOU EXTENSION 4 GRANTED
Thursday, September 8, 2022SOU EXTENSION 4 FILED
Thursday, September 8, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, February 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 7, 2022SOU EXTENSION 3 GRANTED
Monday, February 7, 2022SOU EXTENSION 3 FILED
Monday, February 7, 2022SOU TEAS EXTENSION RECEIVED
Friday, October 8, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 6, 2021SOU EXTENSION 2 GRANTED
Wednesday, October 6, 2021SOU EXTENSION 2 FILED
Wednesday, October 6, 2021SOU TEAS EXTENSION RECEIVED
Friday, April 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 14, 2021SOU EXTENSION 1 GRANTED
Wednesday, April 14, 2021SOU EXTENSION 1 FILED
Wednesday, April 14, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, October 20, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 25, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 25, 2020PUBLISHED FOR OPPOSITION
Wednesday, August 5, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, July 20, 2020ASSIGNED TO LIE
Friday, July 17, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 17, 2020EXAMINER'S AMENDMENT ENTERED
Friday, July 17, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, July 17, 2020EXAMINERS AMENDMENT E-MAILED
Friday, July 17, 2020EXAMINERS AMENDMENT -WRITTEN
Monday, July 6, 2020ASSIGNED TO EXAMINER
Friday, April 24, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, April 18, 2020NEW APPLICATION ENTERED